Title | Type | SJR | H index | Total Docs. (2006) | Total Docs. (3years) | Total Refs. (2006) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2006) | %Female (2006) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Pharmaceutical Design | journal | 1.801 Q1 | 183 | 390 | 915 | 45398 | 4967 | 805 | 5.58 | 116.41 | 29.88 | |
2 | Current Medicinal Chemistry | journal | 1.847 Q1 | 202 | 249 | 597 | 33893 | 3484 | 562 | 5.59 | 136.12 | 30.52 | |
3 | Current Drug Targets | journal | 1.512 Q1 | 119 | 161 | 224 | 19288 | 997 | 205 | 4.41 | 119.80 | 29.90 | |
4 | Mini-Reviews in Medicinal Chemistry | journal | 0.975 Q1 | 107 | 141 | 272 | 11742 | 944 | 257 | 3.60 | 83.28 | 30.16 | |
5 | CNS and Neurological Disorders - Drug Targets | journal | 1.820 Q1 | 96 | 55 | 146 | 8234 | 703 | 136 | 4.64 | 149.71 | 28.86 | |
6 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.464 Q1 | 108 | 47 | 137 | 4962 | 589 | 131 | 4.18 | 105.57 | 35.11 | |
7 | Current Cancer Drug Targets | journal | 2.656 Q1 | 103 | 44 | 141 | 7238 | 990 | 136 | 6.36 | 164.50 | 32.53 | |
8 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.225 Q3 | 27 | 40 | 101 | 3756 | 67 | 91 | 0.66 | 93.90 | 37.00 | |
9 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.240 Q3 | 17 | 39 | 0 | 4574 | 0 | 0 | 0.00 | 117.28 | 29.89 | |
10 | Current Vascular Pharmacology | journal | 1.222 Q1 | 69 | 37 | 112 | 4751 | 422 | 109 | 4.05 | 128.41 | 28.43 | |
11 | Current Drug Safety | journal | 41 | 33 | 0 | 2335 | 0 | 0 | 0.00 | 70.76 | 34.07 | ||
12 | Reviews on Recent Clinical Trials | journal | 35 | 31 | 0 | 2212 | 0 | 0 | 0.00 | 71.35 | 33.82 | ||
13 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.737 Q2 | 43 | 29 | 91 | 4161 | 232 | 91 | 2.42 | 143.48 | 27.59 | |
14 | Anti-Infective Agents | journal | 0.456 Q3 | 26 | 28 | 47 | 3662 | 80 | 43 | 1.70 | 130.79 | 27.54 | |
15 | Current Neuropharmacology | journal | 0.515 Q3 | 103 | 28 | 55 | 3460 | 54 | 52 | 0.98 | 123.57 | 30.56 | |
16 | Infectious Disorders - Drug Targets | journal | 0.965 Q1 | 61 | 27 | 95 | 3047 | 276 | 88 | 2.68 | 112.85 | 41.43 | |
17 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.818 Q2 | 45 | 25 | 112 | 3028 | 290 | 104 | 2.58 | 121.12 | 32.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®